A previous study demonstrated that administration of phenobarbital for up to 7 days to male AP Wistar rats caused alterations in labeling indices (LIS) of several different tissues as determined by immunohistochemical visualization of bromodeoxyuridine (BrdU) incorporation into S-phase nuclei. The pivotal role of the pituitary gland in the function of the endocrine system and changes in circulating hormone levels that result from administration of xenobiotics prompted our consideration of the possible changes in LIS of individual cohorts of the anterior pituitary cell population that may occur as a specific functional adaptation during phenobarbital administration. We evaluated the LIS of individual anterior pituitary cell cohorts by modifying a double immunohistochemical staining method for bromodeoxyuridine and pituitary hormones using a sequential peroxidase-anti-peroxidase (PAp)/alkaline phosphamseantialkaline phosphatase (ApAAP) method employing diamino-543
Introduction
Measures of the replicative activity of cells are becoming increasingly important in investigations of normal and pathological tissue activities. Such assessments have been influential in differentiating among tumor types and, consequently, in the construction of an appropriate therapeutic strategy (Coltrera and Gown, 1991; Kute and Quadri, 1991; Raghavan et al., 1990 IJK. ptember 17, 1993 as 3143158; accepted November 11, 1993 (3A3158). benzidine and New Fuchsin chromogens, respectively. The method was robust and reproducible. Differences were noted in individual anterior pituitary cohort LIS between control and phenobarbital-treated groups, although no statistically signifcant difference was evident. We conclude that no detectable efllens on individual cohort LIS were induced by treatment with phenobarbital for up to 7 days and that any functional adaptation to treatment was associated with inaeased hormone release. We believe that the visualization, identifcation, and quantitation of replicating cells in specific hormone-positive cohorts of the anterior pituitary cell population provide opportunities for undemanding the influence of xenobiotics and disease processes on pituitary function. (J Histochem Cytochem 42543-549, 19%) KEY WORDS: Cell proliferation; Pituitary gland Bromodeoxyuridine (BrdU); Immunohistochemistry; Pituitary hormones; Phenobarbital.
[ 3Hl-thymidine) markers of replicating cells (Hall and Levison, 1990; Hanazono et al., 1990) .
Our interest and that of others has lain in evaluating the usefulness of measures of cell proliferation and differentiation as indicators of the non-genotoxic carcinogenic action of potential pharmaceutical agents Ames and Gold, 1990a.b; BogdanEy et al., 1990 Goldsworthy et al., 1990 . Whereas genotoxic carcinogens are detectable in in vitro tests, evidence for the carcinogenic action of non-genotoxic carcinogens is difficult to obtain before tumor formation in target organs (Ames et al., 1990; Schulte-Hermann, 1985) , although phenotypically distinct cells have been identified in some organs and described putatively as pre-neoplastic. It is self-evident that the timely identification of these latter compounds is vital during the evaluation oftheir safety.
In a study of the influence on cell replication of daily adminis-tration of phenobarbital (80 mg/kg) to AP Wistar rats for up to 1 week, we observed that the responses were tissue-specific ; i.e., the labeling indices (Us) were elevated, depressed, or were not significantly different in comparison with controls. Moreover, individual tissue components such as proximal vs distal kidney tubule epithelia and endocrine vs exocrine pancreas exhibited highly significant differences in their replicative responses. The induction by phenobarbital of hepatic and extrahepatic drug-metabolizing enzyme systems led us to consider the possible effects of this xenobiotic on circulating levels of humoral factors (hormones and growth factors) that modulate tissue replicative homeostasis (Kan et al., 1991; Hoermann et al., 1989) . For example, the approximate doubling of the thyroid follicular epithelial cell LI on Day 1 of treatment was ascribed to thyroid gland stimulation by increased concentrations of circulating thyroid-stimulating hormone (TSH) resulting from reduced plasma T4 levels due to phenobarbital-induced hepatic clearance of thyroxine glucuronide (McClain, 1989) .
The findings of our previous study, in conjunction with the known drug-metabolizing inductive effects of phenobarbital viewed in the context of the pivotal nature of the pituitary gland in the endocrine system, prompted our attempt to dissect the pituitary LI curve into its component parts. Our prbary objective was to determine whether treatment with phenobarbital influenced the replicative states of specific cohorts of the anterior pituitary cell population as a specific functional adaptation. That is, do changes in LI occur in specific hormone-positive cohorts [e.g., TSH, growth hormone (GH), follicle-stimulating hormone (FSH)] and not in others? An important aspect of this evaluation was the identification of replicating cells according to their hormone specificity, a prerequisite for subsequent quantitation. Accordingly, we modified a method of dual immunolabeling of BrdU-positive nuclei and pituitary hormone-laden anterior pituitary cell cytoplasm that formed the cornerstone of this evaluation.
Materials and Methods

Experimental Design
The experimental design has been described previously in . Briefly, 28 male Alderley Park Wistar rats (6-7 weeks old, 150 g minimal weight) were housed in groups of four per cage, maintained in a regulated environment (12-hr 1ight:dark cycle, 45-70% humidity), and given standard diet (SDS Modified Irradiated R&M No. 1; Special Diet Services, Manea, Cambridge, UK) and potable tapwater ad libitum. Twenty animals (five groups of four each) were given 80 mglkg sodium phenobarbital (Serva; Heidelberg, Germany) in sterile aqueous solution daily by oral intubation for up to 7 days. Eight animals (two groups of four each) received the vehicle only by the same route. Control and treatment groups were sacrificed by halothane (ICI; Macclesfield, UK) overdose on Days 0 and 8, and 1.2, 3, 5, and 7, respectively. Two days before sacrifice, an Alzet osmotic minipump (model 2ML1, delivery 10 pUh, Alza, Palo Alto, CA), primed with sterile physiological saline containing 10 mg/ml BrdU, was implanted sc in the interscapular region.
Tissue Preparation
At necropsy, several tissues and the pituitary gland were placed in ice-cold 10% neutral buffered formalin and fixed by immersion for 14 days at 2-4T ; this time was used to optimize BrdU visualization. Fixed tissue was dehydrated, infiluated with and embedded in paraffin wax. The orientation of the embedded pituitary gland was such as to ensure the provision of sections that contained the anterior, intermediate, and posterior lobes. Sections (3-4 pm thick) were cut and mounted on immunoadhesivecoated slides (Ortho Adhesive; Ortho Diagnostic Systems, High Wycombe, UK) to prevent lifting of tissue sections during immunohistochemical incubation. Mounted sections were dried in an oven (37'C) overnight and stored at ambient temperature until stained. To compare the effects of different section drying temperatures on tissue immunoreactivity, some sections were dried overnight at 5O' C and then stored under similar conditions.
Pre-evahation
The application of digestive enzyme and acid hydrolysis (or vice versa) has been demonstrated by Sugihara et al. (1986) to yield identical levels of BrdU labeling independent of the order of these treatments. Possible pre-treatment damage caused to pituitary hormones before labeling (due to the application of acid hydrolysis) was avoided by employing DNA denaturation treatment after PAP labeling and before APAAP BrdU labeling.
To establish whether false-positive nuclear staining was generated due to acid hydrolysis and New Fuchsin chromogen exposure (similar to that due to the influence of acid hydrolysis on Schiffs reagent; the Feulgen technique), tissue sections were incubated in 1 M HCI at 56°C for 30 min, followed by two applications of New Fuchsin substrate (K698; Dakopatts, Glostrup, Denmark) for 8-10 min each.
AntibodieJ
Polydonals. Six rabbit polydonal antisera to pituitary hormones (Dakopatts) were used in this study. Their optimal dilutions were as follows: luteinizing hormone (LH; 1:100, Code A572). TSH (1:50; Code A574), prolactin (PRL; 1:25; Code A137). GH (1:50; Code A570), EH (1:20; Code A573). and ACTH (1:50; Code A571).
Monoclonal. The optimal dilution for the monoclonal anti-BrdU clone All antibodies were commercially available, characterization data (in-Bu20A (M744; Dakopatts) was 1:25. cluding cross reactivity) being supplied by Dakopatts.
CO-localization Immunohistochemistry
Sequential co-localization of anterior pituitary hormones and BrdU employed a two-step technique. First, specific pituitary hormones were localized by PAP methodology, followed by diaminobenzidine tetrahydrochloride (DAB; Dakopatts) visualization. Second, nucleus-incorporated BrdU was localized and demonstrated by APAAP and New Fuchsin substrate chromogen (Dakopatts).
Rehydrated paraffin sections (3-5 pm thick) were trypsinized in 0.1% trypsin in 0.05 M Eis buffer (pH 7.6, 0.1% CaCI2) at 37% for 15 min and endogenous peroxidases blocked by treatment with methanolic 3 % H202 solution for 10 min. Sections were then incubated in normal swine serum (1:20; Dakopatts) for 20 min, followed by a primary pituitary hormone antibody in PBS (pH 7.6) for 30 min. Sections were then exposed to swine anti-rabbit immunoglobulins (1:lOO; Dakopatts, 2196) followed by horseradish peroxidase anti-rabbit peroxidase complex (1:lOO; Dakopatts, 2113). After tertiary incubation for 30 min, a solution of 3,3'-DAB (1 mg/ml; Dakopatts, S3000) and 0.02% H202 was applied for 15 min. Single PBS washes were carried out between each incubation step, finishing with a rinse in Tris-buffered saline (TBS; O.05M Tris, 0.15 M NaCI, pH 7.6) before and after substrate chromogen application. After acid hydrolysis pre-treatment (1 M HCI for 30 min at 56"C), sections were rinsed in TBS and incubated in normal rabbit serum (1:20; Dakopatts) for 20 min before immersion in monoclonal mouse anti-BrdU (125 in TBS) for 30 min. Incubation of sections in rabbit anti-mouse immunoglobulins (150; Dakopatts, 2259) for 30 mh preceded their immersion in APAAP complex (L5& Dakopatts P850) for 30 min. The tissue sections were rinsed in TBS between each incubation step and finally washed in distilled water before two applications of New Fuchsin chromogen substrate (Dakopatts; K698) for 8-10 min each.
The sections were counterstained lightly with Mayer' s hematoxylin, dehydrated in ethanol, cleared in xylene, and mounted in Hystomount (Hughes and Hughes; Somenet, UK).
Several controls were employed: omission of incubation of pituitary tissue in primary antisen or subsequent incubation steps, incubation with an inappropriate antiserum. i.e., anti G-CSF(1200, Code 4740-0805; Biogenesis, Bournemouth, UK), and application of primary antisera to sections of rat liver derived from this study. AU reactions were negative.
Quantitative Assessment
Sections were examined with a Leitz Ergolux light microscope interfaced via aJVC ky-F3O camera to a Joyce Loebl Magiscan image analysis system (Applied Imaging; Sunderland, UK) at an objective lens magnification of x 40. Interactive redlgreenlbluc color management was employed to enhance red and brown coloration. The distribution of hormone-positive cells in all cohorts appeared to be random by visual inspection. The centd area of the anterior lobe only was employed for quantitative assessments due to artifactual staining ofthe edge of some sections. Assessments were performed on one section per animal under the assumption that the sample was representative of that hormone-positive cohort of the anterior pituitary cell population. Counts ofBrdU(mon0)-immunolabeled nuclei (redl pink), brawn cytoplasm of nucleated pituitary hormone(mono)-immunolabeled cells, BrdUlpituitary hormone dual-labeled cells, and unlabeled (blue) nuclei were obtained from 10 random fields per section. (For the purposes of deriving cohort Lk. only brawn-stained cells that displayed a blue nudear profile were counted. No cytoplasmic fragments in which nuclear profiles were absent were included in the assessment of cohort site.)
The possibility of the introduction of sampling bias due to regional variations in hormone distribution was assessed by comparisons of numbers of specific hormone-positive cells in 10 random fields in each of two sections per pituitary (separated by at least 1 mm) from 14 animals (two 
ReSUltS
Methodology
Early results showed that the red coloration generated by the New resulted in the appearance of increased numbers of BrdU-positive cells that showed pale nuclear staining compared with those that were dried at 37°C. Moreover, many cells dried at 50'C displayed extensive diffusion of the New Fuchsin stain into the cytoplasm, resulting in equivocal staining. It is noteworthy that the increase in temperature from 37 to 50°C resulted in a 30% reduction in pituitary LI, whereas immuncyisualization of pituitary hormones was not temperature-sensitive (Figure 2 ).
Quantitative Assessment
The LI of the anterior pituitary cell population after treatment with phenobarbital for 1 week was similar in degree and pattern to that described previously and therefore validates the employment of New Fuchsin chromogen compared with DAB (Figure 3) . The LIS ofcohorts ofthe anterior pituitary cell population that were positive for specific pituitary hormones, i.e., LH, FSH, GH, trol and test data render it difficult to draw definitive conclusions regarding the influence of phenobarbital on cohort replication rates in the anterior pituitary. The significance of this issue is discussed below.
Discussion
The objective of this study was to attempt a dissection of the anterior pituitary LI profile during daily administration of phenobarbital to AP Wistar rats for up to 1 week, i.e., to determine whether the population LI profile obscured a significant change in the LI of one or more hormone-specific cohorts that could be related to altered cell proliferative activity in other tissues, such as changes in TSH-positive anterior pituitary cell LI and thyroid follicular epithelial cell LI. The double-immunolabeling technique developed for this purpose was effective in identifying BrdU-positive nuclei within hormone-specific cells of the anterior pituitary. However, manual counting with interactive image analysis could be used only for quantitation, as the redlbrown chromogens were not adequately resolvable to enable automated color separation, a prerequisite of automated nuclear discrimination for measurements of tissue LIS. Carbajo et al. (1992) experienced similar counting difficulties during attempts to automate color image quantitation of cell proliferation in dispersed rat anterior pituitary cells using double immunostaining with DAB and nickel-intensified DAB. Confidence in the capability of this dual-immunostaining approach to accurately reflect the LIS of hormone-specific cell cohorts can be obtained only by provision of evidence in support of each component. First, the demonstration of BrdU immunolocalization (APAAP) was similar to that obtained by PAPlDAB visualization in our previous study , the LIS from both studies being closely correlated. In this regard, it was noteworthy that rigorous adherence to incubation conditions was vital in obtaining reliable data, i.e., different section drying temperatures were responsible for diffuse nuclear (New Fuchsin) staining and erroneous LI values (Figure 2 ), although the basis for this phenomenon is unclear. Second, anterior pituitary cell-specific peptide immunocytochemistry was well-defined: the contribution (%) of each cohort to the cell population being in general, closely comparable to data (Table 1) published by others (Carbajo et al., 1992; Dada et al., 1984; Childs, 1983; Childs et al., 1981 Childs et al., ,1982 Nakane et al., 1973; Baker et al., 1972) . However, it should be noted that the values obtained are underestimates, as the objective of our study required an assessment of BrdU-positive or -negative nuclei and brownstained cells were counted only ifthey contained a nuclear profile. Despite the trends shown in GH-, TSH-, and LH-positive cohort Us, the lack of statistically significant dlfferences between phenobarbital-treated and control anterior pituitary cell LIS provides no unequivocal evidence of a treatment-related influence on cohort replicative rates. In the absence of evidence in support of a regional distribution of nuclear labeling within the pituitary, the wide range of cohort LI values is probably due to biological variation, i.e., interanimal differences. We conclude that the technique is both reproducible and appropriate for separation of the anterior pituitary cell population into its component parts (cohorts).
The rapid replicative response shown by thyroid follicular epi-thelial cells in this same study demonstrated by an approximate doubling of LI on Day 1 requires an explanation. McClain (1989) and McClain et al. (1989) have shown that phenobarbital administration to rats results in induction of thyroxine glucuronyltransferase, leading to enhanced hepatic clearance of thyroxine glucuronide. Reduction in the levels of circulating thyroid hormones stimulates the release of pituitary TSH and, consequently, thyroid follicular epithelial cell hyperplasia and hypertrophy. In this context, it appears that the response of the TSHpositive cohort to relatively short-term (7 days) exposure to phenobarbital is due to enhanced TSH secretion and not to altered cell replication. Moreover, Chin et al. (1985) showed that TSH mRNA levels fell in pituitaries of thyroidectomized mice within 24 hr of exogenous T3 administration, underlining the rapid cell response to altered concentrations of circulating hormone. Whether or not this adaptive response to xenobiotic administration is sustained during longer exposures is an intriguing question. It is conceivable that at some point during xenobiotic treatment, increased peptide secretion by the original anterior pituitary cell cohort is inadequate to maintain circulating hormone levels and increased cell replication (proliferation) occurs. Many chronic studies undertaken as part of the safety evaluation of potential new chemicals and pharmaceutical agents attest to this possibility, as pituitary tumors, such as mammotrope and gonadotrope adenomas, appear in significantly elevated numbers as a function of xenobiotic identity, dose, and duration of exposure. Hill et al. (1989) note that pituitary hyperplasia and neoplasia appear to result from the same treatments that cause thyroid neoplasia, conditions leading to prolonged decrease in circulating thyroid hormone levels and excessive pituitary TSH secretion. Supporting evidence has been provided by studies in which goitrogen treatment (Griesbach et al., 1945) , surgical or 1311-induced thyroidectomy (Carlton and Gries, 1983; Doniach and Williams, 1962) , or iodine deficiency (Axelrod and Leblond, 1955) produced increases in anterior pituitary thyrotrophs and swollen "thyroidectomy cells." These cells contain TSH and may progress to TSH-secreting adenomas (Furth et al., 1973; Bielschowsky, 195S) , although other authors have failed to demonstrate such a change (Ohshima and Ward, 1986 ). Other influences (e.g., disease, dietary, and environmental factors) that exert an effect on the hypothalamus-pituitary-target organ axis by modifying regulatory feedback mechanisms would be expected to produce functional changes and perhaps hyperstimulation leading to cell proliferation in the cohorts of anterior pituitary cells associated with individual control mechanisms only (Berkvens et al., 1980; Furth et al., 1976) . Increased incidence of pituitary tumors in aging rats has been widely reported and ascribed to agerelated perturbation in the hypothalamus-pituitary-target organ axis (Sandusky et al., 1988; McComb et al., 1984; Berkvens et al., 1980) . Furthermore, high-calorie or high-protein diets have been linked as causative factors to observed high incidences of pituitary neoplasms in rats (Berry, 1986; Furth et al., 1976) .
It seem reasonable to infer that altered hormonal status whereby, for example, thyroid follicular epithelial cell and anterior pituitary thyrotroph stimulation of cell proliferation occurs, may be a common feature of similar xenobiotic-induced changes in other hormone-specific anterior pituitary cell cohorts.
